|
ES2561048T3
(es)
|
2004-07-23 |
2016-02-24 |
Acceleron Pharma Inc. |
Polipéptidos del receptor ActRII
|
|
ME00380B
(me)
|
2005-11-23 |
2011-10-10 |
Acceleron Pharma Inc |
Amtagonisti aktivin-actriia i primjene za stimulaciju rasta kosti
|
|
US8128933B2
(en)
|
2005-11-23 |
2012-03-06 |
Acceleron Pharma, Inc. |
Method of promoting bone growth by an anti-activin B antibody
|
|
US8895016B2
(en)
|
2006-12-18 |
2014-11-25 |
Acceleron Pharma, Inc. |
Antagonists of activin-actriia and uses for increasing red blood cell levels
|
|
US9526759B2
(en)
|
2007-02-01 |
2016-12-27 |
Acceleron Pharma Inc. |
Activin-actriia antagonists and uses for treating or preventing breast cancer
|
|
TW201940502A
(zh)
|
2007-02-02 |
2019-10-16 |
美商艾瑟勒朗法瑪公司 |
衍生自ＡｃｔＲＩＩＢ的變體與其用途
|
|
KR101672156B1
(ko)
|
2007-02-09 |
2016-11-02 |
악셀레론 파마 인코포레이티드 |
액티빈-ＡｃｔＲⅡＡ 길항제 및 암 환자에서 골 생장을 촉진시키기 위한 이의 용도
|
|
CN107412734A
(zh)
|
2007-09-18 |
2017-12-01 |
阿塞勒隆制药公司 |
活化素‑actriia拮抗剂和减少或抑制fsh分泌的用途
|
|
US8216997B2
(en)
|
2008-08-14 |
2012-07-10 |
Acceleron Pharma, Inc. |
Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
|
|
LT3750552T
(lt)
|
2008-08-14 |
2023-06-26 |
Acceleron Pharma Inc. |
Gdf gaudyklės
|
|
CA2749544A1
(en)
|
2009-01-13 |
2010-07-22 |
Acceleron Pharma Inc. |
Methods for increasing adiponectin
|
|
MX385318B
(es)
|
2009-06-08 |
2025-03-18 |
Acceleron Pharma Inc |
Metodos para aumentar adipocitos termogenicos.
|
|
JP2012529294A
(ja)
|
2009-06-12 |
2012-11-22 |
アクセルロン ファーマ， インコーポレイテッド |
切断型ＡｃｔＲＩＩＢ−Ｆｃ融合タンパク質
|
|
MX336152B
(es)
|
2009-08-29 |
2016-01-08 |
Abbvie Inc |
Proteinas terapeutico de union a dll4.
|
|
EP2501400B1
(en)
|
2009-11-17 |
2017-11-01 |
Acceleron Pharma, Inc. |
Actriib proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy
|
|
US9849192B2
(en)
|
2009-11-18 |
2017-12-26 |
Rutgers, The State University Of New Jersey |
Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodies
|
|
CA2818237C
(en)
|
2009-11-18 |
2021-05-18 |
University Of Medicine And Dentistry Of New Jersey |
Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodies
|
|
MX2012006406A
(es)
|
2009-12-04 |
2012-07-25 |
Genentech Inc |
Anticuerpos multiespecificos, analogos de anticuerpo, composiciones y metodos.
|
|
AU2010330794A1
(en)
|
2009-12-18 |
2012-06-21 |
Amgen Inc. |
Wise binding agents and epitopes
|
|
EP3072904A1
(en)
*
|
2010-03-02 |
2016-09-28 |
Abbvie Inc. |
Therapeutic dll4 binding proteins
|
|
WO2012064771A1
(en)
|
2010-11-08 |
2012-05-18 |
Acceleron Pharma, Inc. |
Actriia binding agents and uses thereof
|
|
EP2785736A4
(en)
|
2011-11-30 |
2015-12-09 |
Wellstat Diagnostics Llc |
ASSAYS, ANTIBODIES, IMMUNOGENS AND COMPOSITIONS IN CONNECTION WITH 5-FU
|
|
AU2013203422A1
(en)
*
|
2012-01-06 |
2013-07-18 |
Bioalliance C.V. |
Anti-transferrin receptor antibodies and methods using same
|
|
FR2987293B1
(fr)
*
|
2012-02-27 |
2014-03-07 |
Michelin & Cie |
Procede et appareil pour realiser des objets tridimensionnels a proprietes ameliorees
|
|
EP2904015A4
(en)
*
|
2012-10-02 |
2016-10-05 |
Univ Rutgers |
TARGETED RELEASE OF ANTIBODIES TO ACTIVATED MATRIPTASE-CONJUGATED TOXINS
|
|
RU2018145985A
(ru)
|
2012-11-02 |
2019-02-18 |
Селджин Корпорейшн |
Антагонисты активина-actrii и их применение для лечения нарушений костной ткани и других нарушений
|
|
HK1211599A1
(en)
|
2012-11-08 |
2016-05-27 |
Eleven Biotherapeutics, Inc. |
Il-6 antagonists and uses thereof
|
|
US20140171356A1
(en)
*
|
2012-12-12 |
2014-06-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Chemically immobilized wnt protein and methods of use
|
|
CA2922937A1
(en)
*
|
2013-09-05 |
2015-03-12 |
Duke University |
Nav1.7 antibodies and methods of using the same
|
|
US10035847B2
(en)
|
2013-10-02 |
2018-07-31 |
The Rockefeller University |
Amyloid protofibril antibodies and methods of use thereof
|
|
TN2016000553A1
(en)
|
2014-06-13 |
2018-04-04 |
Acceleron Pharma Inc |
Methods and compositions for treating ulcers
|
|
MA41052A
(fr)
|
2014-10-09 |
2017-08-15 |
Celgene Corp |
Traitement d'une maladie cardiovasculaire à l'aide de pièges de ligands d'actrii
|
|
EP4268843B1
(en)
|
2014-11-07 |
2025-09-03 |
F. Hoffmann-La Roche Ltd |
Improved il-6 antibodies
|
|
DK3227675T3
(da)
|
2014-12-03 |
2023-05-30 |
Celgene Corp |
Activin-actrii-antagonister og anvendelser til behandling af myelodysplastisk syndrom
|
|
CA3012350A1
(en)
|
2016-02-23 |
2017-08-31 |
Sesen Bio, Inc. |
Il-6 antagonist formulations and uses thereof
|
|
EP3429586A4
(en)
|
2016-03-18 |
2020-03-11 |
Rutgers, the State University of New Jersey |
TARGETING TUMOR CELLS WITH CHEMOTHERAPEUTIC AGENTS CONJUGATED TO ANTI-MATRIPTASE ANTIBODIES BY IN VIVO-CLAVABLE LINKAGES
|
|
EP3448875A4
(en)
*
|
2016-04-29 |
2020-04-08 |
Voyager Therapeutics, Inc. |
COMPOSITIONS FOR TREATING A DISEASE
|
|
US11518818B2
(en)
*
|
2017-01-06 |
2022-12-06 |
The Regents Of The University Of California |
Therapeutic anti-IgE antibodies and methods and compositions thereof
|
|
US11021540B2
(en)
*
|
2017-09-07 |
2021-06-01 |
Augusta University Research Institute, Inc. |
Antibodies to programmed cell death protein 1
|
|
EP4000633A4
(en)
*
|
2019-07-12 |
2024-02-21 |
Kyoto University |
NEUTRALIZING ANTIBODIES FOR THE TREATMENT OF DENTAL REGENERATION TARGETING THE USAG-1 MOLECULE
|
|
CN112180099B
(zh)
*
|
2020-09-15 |
2022-07-29 |
江南大学附属医院 |
子宫内膜异位症血清标志物的应用
|
|
WO2023147470A2
(en)
|
2022-01-28 |
2023-08-03 |
Georgiamune Inc. |
Antibodies to programmed cell death protein 1 that are pd-1 agonists
|
|
CN115322258B
(zh)
*
|
2022-05-31 |
2024-08-13 |
武汉真福医药股份有限公司 |
一种单克隆抗体qkma-1g41及其应用
|
|
CN115304677B
(zh)
*
|
2022-06-19 |
2024-08-16 |
湖北真福医药有限公司 |
一种抗枯草芽孢杆菌纤溶酶的单克隆抗体qkma-9a10及应用
|
|
CN116712533B
(zh)
*
|
2023-07-03 |
2024-02-02 |
广东暨安特博生物科技有限公司 |
一种sostdc1蛋白在制备治疗皮肤病产品中的应用
|